Biospace
Published November 17, 2026 · Updated November 18, 2026
Ensysce Biosciences Announces Participation in Upcoming Investor Conferences
Read the full story at Biospace
Ensysce Biosciences is a clinical-stage biotechnology company developing novel neuroplastogenic therapies using psychedelics that go beyond mood.
Surfaced by this Google Alert
- Psychedelic biotech